MUC7
Basic information
Region (hg38): 4:70430492-70482997
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MUC7 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 19 | 23 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 19 | 5 | 1 |
Variants in MUC7
This is a list of pathogenic ClinVar variants found in the MUC7 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
4-70474042-T-G | not specified | Likely benign (Mar 24, 2023) | ||
4-70480821-A-G | not specified | Uncertain significance (Apr 09, 2024) | ||
4-70480850-C-G | not specified | Uncertain significance (Jan 31, 2022) | ||
4-70480889-C-T | not specified | Uncertain significance (Aug 10, 2021) | ||
4-70480899-T-C | not specified | Likely benign (Dec 26, 2023) | ||
4-70480944-A-G | not specified | Uncertain significance (Sep 25, 2023) | ||
4-70480949-C-A | not specified | Uncertain significance (Aug 08, 2022) | ||
4-70480950-G-A | not specified | Uncertain significance (Jan 24, 2023) | ||
4-70480950-G-T | not specified | Uncertain significance (May 30, 2024) | ||
4-70480979-A-G | not specified | Uncertain significance (Jun 21, 2023) | ||
4-70480990-C-G | Likely benign (Aug 01, 2022) | |||
4-70481027-G-C | not specified | Uncertain significance (Sep 17, 2021) | ||
4-70481038-C-A | not specified | Uncertain significance (Feb 15, 2023) | ||
4-70481045-G-A | not specified | Uncertain significance (Mar 31, 2024) | ||
4-70481100-C-T | not specified | Uncertain significance (Mar 25, 2024) | ||
4-70481195-G-A | not specified | Uncertain significance (Dec 01, 2022) | ||
4-70481292-C-T | not specified | Uncertain significance (Jun 24, 2022) | ||
4-70481315-G-A | not specified | Uncertain significance (Feb 28, 2024) | ||
4-70481342-C-G | not specified | Uncertain significance (Mar 02, 2023) | ||
4-70481399-C-T | not specified | Likely benign (Jun 01, 2024) | ||
4-70481421-CATCTTCCTCAGCTCCACCAGAGACCACAGCTGCCCCACCCACACCTTCTGCAACTACACCAGCTCCACT-C | Asthma, protection against | Benign (Jul 07, 2018) | ||
4-70481439-C-T | not specified | Uncertain significance (Dec 28, 2022) | ||
4-70481612-A-G | not specified | Uncertain significance (Jun 03, 2022) | ||
4-70481637-C-T | not specified | Uncertain significance (Oct 25, 2023) | ||
4-70481696-C-G | not specified | Uncertain significance (Mar 24, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MUC7 | protein_coding | protein_coding | ENST00000413702 | 2 | 52506 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0146 | 0.464 | 125021 | 0 | 2 | 125023 | 0.00000800 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.326 | 209 | 196 | 1.07 | 0.00000983 | 2348 |
Missense in Polyphen | 13 | 18.844 | 0.68987 | 215 | ||
Synonymous | 1.19 | 61 | 74.0 | 0.824 | 0.00000391 | 917 |
Loss of Function | -0.773 | 2 | 1.12 | 1.79 | 4.76e-8 | 12 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000623 | 0.0000618 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00000886 | 0.00000885 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: May function in a protective capacity by promoting the clearance of bacteria in the oral cavity and aiding in mastication, speech, and swallowing. Binds P.aeruginosa pili. {ECO:0000269|PubMed:11378823, ECO:0000269|PubMed:8104046}.;
- Disease
- DISEASE: Asthma (ASTHMA) [MIM:600807]: The most common chronic disease affecting children and young adults. It is a complex genetic disorder with a heterogeneous phenotype, largely attributed to the interactions among many genes and between these genes and the environment. It is characterized by recurrent attacks of paroxysmal dyspnea, with wheezing due to spasmodic contraction of the bronchi. {ECO:0000269|PubMed:11378823}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.;
- Pathway
- Salivary secretion - Homo sapiens (human);Post-translational protein modification;Dectin-2 family;Metabolism of proteins;C-type lectin receptors (CLRs);Innate Immune System;Immune System;Termination of O-glycan biosynthesis;O-linked glycosylation of mucins;O-linked glycosylation
(Consensus)
Recessive Scores
- pRec
- 0.133
Intolerance Scores
- loftool
- 0.927
- rvis_EVS
- 2.46
- rvis_percentile_EVS
- 98.58
Haploinsufficiency Scores
- pHI
- 0.0590
- hipred
- N
- hipred_score
- 0.123
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.164
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- stimulatory C-type lectin receptor signaling pathway;O-glycan processing;killing of cells of other organism;antimicrobial humoral immune response mediated by antimicrobial peptide
- Cellular component
- Golgi lumen;plasma membrane;other organism cell membrane;extracellular exosome;other organism cytoplasm
- Molecular function
- protein binding